Upcoming Financial Results Announcement by Ekso Bionics
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a renowned leader in exoskeleton technology designed for both medical and industrial usage, is gearing up to release its financial and operational results for the final quarter and the entire year of 2024. This highly anticipated announcement is set to take place shortly after market trading concludes on the specified date in March 2025.
Conference Call Details
The management team at Ekso Bionics will conduct a live conference call at 1:30 p.m. Pacific Time for investors and analysts. This discussion is an excellent opportunity for stakeholders to gain insights into the company's performance and recent strategic developments. During the conference call, key financial metrics will be shared, providing a comprehensive overview of Ekso Bionics' business trajectory.
How to Join the Conference Call
Interested participants can join the conversation by calling 877-407-6184 if they are located domestically, or by dialing 201-389-0877 for international connections. The conference call will be available to listen to in real-time and will also be archived for future access on the company’s official website.
Insights into Ekso Bionics
Ekso Bionics is much more than a company producing advanced technology; it represents a significant shift in how we understand mobility and rehabilitation. As the sole provider of a diverse range of exoskeleton products, Ekso Bionics empowers individuals with limited mobility, enabling them to experience walking and standing. Notably, the company's products are utilized in various sectors, including healthcare and industry, significantly enhancing human performance.
Innovative Solutions for Every Need
Founded in 2005, Ekso Bionics has consistently expanded its portfolio. The company works relentlessly to introduce new and innovative solutions, capitalizing on the latest advancements in technology. Their mission focuses on amplifying human potential, ensuring that their technologies support users in a comprehensive range of applications, from rehabilitation to workplace enhancement.
Headquarters and Corporate Information
The company operates out of the San Francisco Bay Area, which places it at the heart of technological innovation and development. Being part of the Nasdaq Capital Market allows Ekso Bionics to maintain a strong financial presence and engage with investors effectively. For those looking to learn more, further details can be found on their website, or you can follow their latest updates on social media platforms.
Contact Information for Inquiries
For any questions regarding their financial results or corporate strategies, Stephen Kilmer from Investor Relations can be reached directly at (646) 274-3580. Additionally, Stephen is available via email for more in-depth inquiries.
Frequently Asked Questions
What is the date for Ekso Bionics' financial results announcement?
Ekso Bionics plans to announce its financial results for the fourth quarter and full year of 2024 on a Monday in March 2025.
How can I participate in the conference call?
You can join by calling 877-407-6184 for domestic attendance or 201-389-0877 for international participation.
What technologies does Ekso Bionics specialize in?
Ekso Bionics specializes in exoskeleton technology that enhances strength and mobility across various medical and industrial applications.
Where is Ekso Bionics headquartered?
Ekso Bionics is headquartered in the San Francisco Bay Area, a hub for technological advancements.
Who can I contact for more information about Ekso Bionics?
For inquiries, you can reach out to Stephen Kilmer, the Investor Relations contact, through phone or email for assistance.
